Johnson & Johnson (J&J) has announced the start of a safety and immunogenicity clinical trial in Sierra Leone of...
Singapore: Singapore's ASLAN pharmaceuticals recently announced that the Food and Drug Administration (FDA) has granted ...
Singapore: Taiwan's TaiGen Biotechnology has initiated first burixafor trial for relapsed or refractory acute myeloid le...
Singapore: Bayer's anticoagulant drug, Xarelto (rivaroxaban), has been approved by the China Food and Drug Administratio...
Singapore: Taiwanese company ScinoPharm and US-based Foresee Pharmaceuticals have signed an investment agreement to form...
Singapore: Australian biotechnology company, Novogen's lead candidate product, TRXE-009, has shown a positive result in ...
Singapore: Australian drug delivery technology company, Phosphagenics has achieved succes in its multi-dose oxymorphone ...
Singapore: Australia based Viralytics has initiated a clinical trial to assess its oncolytic virus, Cavatak, in combinat...
Singappore: US Food and Drug Administration (FDA) has granted orphan drug designation to chemotherapy drug candidate Can...
Tokyo: Japan's pharma giant Eisai Co Ltd announced that its European regional headquarters Eisai Europe Ltd has submitte...
Singapore: Baxter has acquired Oncaspar (pegaspargase) product portfolio, a first-line biologic used as part of a multi-...
Singapore: Prana Biotechnology announced the successful completion of Reach2HD, a phase II clinical trial in patients wi...
Singapore: Scientists at A*Star's Singapore Immunology Network (SIgN) have discovered a clue that has the potential to c...
Mumbai: Lupin is setting up a R&D center in the US, and has hired the R&D head of Teva Pharmaceuticals and other...
Singapore: Janssen Pharmaceutical has terminated the research and development alliance with China based Hutchison Mediph...
In 2005, Novartis, a leading healthcare solution provider, decided to partner with The National Center For Genetic Engin...
Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase i...
Singapore:Â Dengue, also known as break bone fever, is currently the most common vector-borne disease. The World Healt...
Singapore: Novartis received US FDA breakthrough therapy designation for BYM338 (bimagrumab) for sporadic inclusion body...
Singapore: Singapore based start-up firm, NMT Pharmaceuticals, has acquired an exclusive worldwide license right to furt...
Singapore: Boehringer Ingelheim and Circuit Therapeutics have formed a three-year collaboration to focus on investigatin...
Takeda Pharmaceutical Company Ltd and Paris-headquartered Enterome Bioscience SA have entered into a strategic drug disc...
Japan's Eisai Co Ltd has announced that its US subsidiary Eisai Inc. has received approval from the US Food and Drug Adm...
Singapore: SCIEX, a global leader in life science analytical technologies, and the Protein and Proteomics Centre (PPC) u...
The Japanese Pharmaceutical Affairs and Food Sanitation Council (PAFSC) has recommended an approval for Madrid-based Pha...
